(Q34647911)

3 August 2017

title

Comparison of systems for assessment of post-therapeutic response to sorafenib for hepatocellular carcinoma (English)

1 reference

3 August 2017

Masatoshi Kudo

13

0 references

author name string

Tadaaki Arizumi

1

1 reference

3 August 2017

Kazuomi Ueshima

2

1 reference

3 August 2017

Haruhiko Takeda

3

1 reference

3 August 2017

Yukio Osaki

4

1 reference

3 August 2017

Masahiro Takita

5

1 reference

3 August 2017

Tatsuo Inoue

6

1 reference

3 August 2017

Satoshi Kitai

7

1 reference

3 August 2017

Norihisa Yada

8

1 reference

3 August 2017

Satoru Hagiwara

9

1 reference

3 August 2017

Yasunori Minami

10

1 reference

3 August 2017

Toshiharu Sakurai

11

1 reference

3 August 2017

Naoshi Nishida

12

1 reference

3 August 2017

publication date

6 February 2014

1 reference

Journal of Gastroenterology

3 August 2017

published in

1 reference

3 August 2017

volume

49

1 reference

3 August 2017

issue

12

1 reference

3 August 2017

page(s)

1578-1587

1 reference

Creative Commons Attribution-NonCommercial 2.5 Generic

3 August 2017

copyright license

start time

6 February 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Signaling pathways governing tumor angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258615

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258615

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258615

Molecularly targeted therapy for hepatocellular carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258615

Comparison of the effects of the kinase inhibitors imatinib, sorafenib, and transforming growth factor-beta receptor inhibitor on extravasation of nanoparticles from neovasculature.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258615

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258615

Molecular targeted therapies in hepatocellular carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258615

Sorafenib in advanced hepatocellular carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258615

Design and endpoints of clinical trials in hepatocellular carcinoma.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258615

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258615

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258615

Reporting results of cancer treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258615

Evaluation of responses to chemoembolization in patients with unresectable hepatocellular carcinoma.

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00535-014-0936-0

General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Nationwide Follow-Up Survey and Clinical Practice Guidelines: The Outstanding Achievements of the Liver Cancer Study Group of Japan

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24499826

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00535-014-0936-0

1 reference

release_nf6j4pdxprgh3fai27apwolfhu

3 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nf6j4pdxprgh3fai27apwolfhu

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMC publication ID

4258615

1 reference

3 August 2017

1 reference